Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Patrick Amstutz
Michael Tobias Stumpp
Alexander Zürcher
Philippe Legenne
Renate Gloggner
Board:
Agnete Brunsvik Fredriksen
Dominik Höchli
Michael Vasconcelles
Steven Holtzman
Vito Palombella
Sandipkumar S. Kapadia
William Burns
Shareholding in %:
BVF Partners LP 21.14
EcoR1 Capital, LLC 2.69
GAM Investment Management (Switzerland) AG 2.53
Michael Tobias Stumpp 1.9
Novartis AG 4.31
Patrick Amstutz 4
Suvretta Capital Management LLC 10.62
UBS Asset Management Switzerland AG 4.32
Union Bancaire Privée, UBP SA 1.06
Zürcher Kantonalbank (Investment Management) 0.84
Freefloat 46.59
Address: Wagistrasse 14, 8952 Schlieren
T: +41-44-755-77-00
F: +41-44-755-77-07
I: http://www.molecularpartners.com
E: info@molecularpartners.com